Richard a Drage

Richard a Drage covers 8 companies with a founder-verified check from Richard a Drage, concentrated in Biotech. Round sizes are not disclosed for these companies, so this report lists the verified positions rather than dollar totals.

• Verified portfolio companies: 8
• Sector mix: Biotech 6
• Headquarters mix: Boston 2 · Cambridge 2 · Guildford 1 · Bothell 1

Richard a Drage — verified positions

• Imbria Pharmaceuticals
• Verdiva Bio
• Curevo
• Millendo Therapeutics
• KalVista Pharmaceuticals
• Alnylam Pharmaceuticals
• Stylus Medicine
• Bambusa Therapeutics

Richard A. Drage — related firms and companies (56)

• Wellington Funds (US) LLC
• Nancy Zimmerman
• Andrew Boyd
• Peter Y. Chung
• Summit Partners Public Asset Management, LLC
• Adam H. Hennessey
• Scott Charles Collins
• Craig David Frances
• Frederic H. Morris
• M33 Growth LLC
• Ross M. Jones
• Ricardo C. Calvillo
• Mike Volpe
• John Kelly
• Timothy Rowe
• Jennifer Lum
• Rory Vandamme
• Peter Boyce
• Jonathan Bush
• Colin Butterfield
• James McCann
• Paul Sagan
• Matthew Rich
• Christopher Lynch
• Carl Byers
• SCS Private Investment GP, LLC
• Ommer Chohan
• Timothy A. Springer
• Dharmesh Shah
• Brian Kenny
• Barbara Clarke
• Anand More
• Omar Amirana
• TJ Mahony
• Dewey J. Awad
• Asad Butt
• Alan Crane
• Timothy R. D'Arcy
• Investors like Richard A. Drage
• Edwin Kania
• WindSail Capital Group, LLC
• John Robert Carroll
• David Martirano
• Semyon Dukach
• Wellington Management Company LLP
• Rachel Orston
• Cory Pavlik
• Andrew L. Walker
• Gordon Jones
• Gabriel Ling
• Christopher J. Hadley
• Carmine Petrone
• Jere Doyle
• Young Lee
• Luke Burns
• Roy Rodenstein

Richard A. Drage profile · All research reports